In the context of HCC, immune checkpoint molecules, such as PD-1/PD-L1, and tumor-infiltrating lymphocytes (TILs) have been implicated as significant factors influencing prognosis and response to immunotherapy (8). Here, CD274 is linked to hepatocellular carcinoma.